Thirdly, we use the combined genetic effect of the four PSA-SNPs to genetically correct PSA level, and hypothesise that this corrected level would better identify prostate cancers at high risk of progression compared to those with low risk than the standard single PSA threshold (PSA≥3ng/mL). The gene discussed is KLK3; the disease is prostate cancer.